Clinical Trials
5 trialsNCT02573324 2023-05-11
Intellance1
AbbVie
Phase 3 Completed
NCT03419403 2021-04-14
UNITE Study: Understanding New Interventions With GBM ThErapy
AbbVie
Phase 3 Terminated
NCT02343406 2020-05-22
INTELLANCE-2
AbbVie
Phase 2 Completed
NCT02365662 2018-03-30
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
AbbVie
Phase 1 Terminated
NCT01800695 2017-11-21
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
AbbVie
Phase 1 Completed